A detailed history of Teacher Retirement System Of Texas transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Teacher Retirement System Of Texas holds 15,062 shares of TVTX stock, worth $265,994. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,062
Previous 16,727 9.95%
Holding current value
$265,994
Previous $129,000 3.88%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$5.26 - $8.28 $8,757 - $13,786
-1,665 Reduced 9.95%
15,062 $124,000
Q1 2024

May 06, 2024

SELL
$7.18 - $9.82 $1,967 - $2,690
-274 Reduced 1.61%
16,727 $129,000
Q4 2023

Feb 07, 2024

SELL
$5.44 - $9.5 $9,808 - $17,128
-1,803 Reduced 9.59%
17,001 $153,000
Q3 2023

Oct 31, 2023

BUY
$7.64 - $17.25 $12,537 - $28,307
1,641 Added 9.56%
18,804 $168,000
Q2 2023

Jul 19, 2023

SELL
$15.3 - $22.61 $26,591 - $39,296
-1,738 Reduced 9.2%
17,163 $264,000
Q1 2023

May 12, 2023

BUY
$17.82 - $22.89 $43,855 - $56,332
2,461 Added 14.97%
18,901 $425,000
Q4 2022

Feb 10, 2023

SELL
$18.47 - $26.14 $24,989 - $35,367
-1,353 Reduced 7.6%
16,440 $346,000
Q3 2022

Nov 03, 2022

BUY
$22.91 - $28.63 $204,677 - $255,780
8,934 Added 100.85%
17,793 $438,000
Q2 2022

Aug 09, 2022

SELL
$20.94 - $30.01 $51,784 - $74,214
-2,473 Reduced 21.82%
8,859 $215,000
Q1 2022

May 09, 2022

BUY
$23.61 - $30.6 $22,783 - $29,529
965 Added 9.31%
11,332 $292,000
Q4 2021

Feb 10, 2022

BUY
$24.34 - $31.17 $49,580 - $63,493
2,037 Added 24.45%
10,367 $322,000
Q3 2021

Nov 09, 2021

BUY
$12.98 - $25.03 $108,123 - $208,499
8,330 New
8,330 $202,000

Others Institutions Holding TVTX

About Travere Therapeutics, Inc.


  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.13B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Teacher Retirement System Of Texas Portfolio

Follow Teacher Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Teacher Retirement System Of Texas with notifications on news.